Russian Direct Investment Fund or RDIF has partnered with Wockhardt to produce and supply Sputnik V and Sputnik Light COVID-19 vaccines. Enso Healthcare is the coordinating partner for RDIF for sourcing Sputnik-V vaccines in India. Sputnik is already registered in 69 countries with 3.7 billion people. Sputnik-V has shown 83.1% efficacy against the Delta variant, which is the biggest risk for the world today.
Russian Direct Investment Fund or RDIF has partnered with Wockhardt to produce and supply Sputnik V and Sputnik Light COVID-19 vaccines. Enso Healthcare is the coordinating partner for RDIF for sourcing Sputnik-V vaccines in India. Sputnik is already registered in 69 countries with 3.7 billion people. Sputnik-V has shown 83.1% efficacy against the Delta variant, which is the biggest risk for the world today.